Files

Download

Download Full Text (1.4 MB)

Publication Date

Spring 5-10-2026

Keywords

Ewing Sarcoma, Pediatric Cancer, Everolimus, mTOR, Apoptosis, Proliferation, Migration, qRTPCR, Incucyte, Tissue Culture

Description

Ewing Sarcoma (ES) is an aggressive pediatric bone cancer characterized by rapid cell proliferation and poor prognosis, making the identification of therapeutic targets critical. One of  the mechanistic targets is rapamycin (mTOR) signaling pathway, which is critical for regulating cell growth, proliferation, and survival. Abnormal activation of the mTOR signaling pathway has been linked to the progression of ES, as it drives uncontrolled cell growth and apoptosis resistance. Because mTOR represents a promising therapeutic target for ES treatment, we hypothesized that inhibiting mTOR activity through an siRNA-mediated knockdown or through Everolimus drug treatment, would reduce cell proliferation and promote ES cell apoptosis. Everolimus is an FDA-approved mTOR inhibitor that functions by binding to mTORC1 and blocking downstream signaling involved in cell growth and survival. To test this hypothesis, ES cells were treated with siRNA-mediated knockdown of mTOR and Everolimus at concentrations of 0.1µM and 1.0µM, and cell proliferation, apoptosis, and gene expression were measured using Incucyte live-cell imaging, Caspase 3/7 fluorescence, and qRT-PCR, respectively. Our results showed that mTOR inhibition successfully reduced mTOR gene expression and increased Caspase 3/7 activity, showing an increase in apoptosis, with the greatest effect observed at 1.0µM Everolimus together with siMTOR knockdown. Our findings support the hypothesis that mTOR inhibition reduces cell proliferation and promotes apoptosis in ES cells, suggesting that it is a potential therapeutic treatment for Ewing Sarcoma.

Collection

Cell and Molecular Methods

Format

pdf

Size or Duration

9 Pages

City

San Antonio

Everolimus and siRNA-Mediated mTOR Inhibition Reduces Proliferation and Promotes Apoptosis in Ewing Sarcoma Cells

Share

COinS